Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ATHE stock hub

Alterity Therapeutics Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ATHEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

86.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ATHE

In the news

Latest news · ATHE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-47

P25 -106.6P50 -46.9P75 -3.1

ROIC-35.3

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ATHE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

AUD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001131343
Company name	Alterity Therapeutics Limited
Country	Australia
Country code	US
Cusip	02155X106
Employees	9
Employees Change	-1%
Employees Change Percent	-10
Enterprise value	$51.1M
Exchange	NASDAQ
Financial currency	AUD
First seen	2026-05-09
Industry	Biotechnology
Isin	US02155X2053
Last refreshed	2026-05-10
Market cap	$86.6M
Market cap category	Micro-Cap
Price	$4.66
Price currency	USD
Rev Per Employee	491,849.11x
Sector	Healthcare
Sic	2834
Symbol	ATHE
Website	https://alteritytherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.23%
EV/Sales	11.54x
FCF yield	-11.48%
P/B ratio	2.39x
P/S ratio	19.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-264.66%
EBITDA Margin	-264.46%
Gross margin	97.55%
Gross Profit	$4.3M
Gross Profit Growth	82.69%
Gross Profit Growth Q	49.94%
Gross Profit Growth3 Y	10.25%
Net Income	$-9.7M
Net Income Growth Years	1%
Pretax Margin	-217.9%
Profit Margin	-219.85%
Profit Per Employee	$-1.1M
ROA	-32.54
Roa5y	-35.37
ROCE	-32.33
ROE	-47.02
Roe5y	-63.09
ROIC	-35.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.78%
Cagr15y	-20.05%
Cagr1y	17.99%
Cagr20y	-14.2%
Cagr3y	15.3%
Cagr5y	-18.68%
EPS Growth Years	2
Revenue Growth	78.18x
Revenue Growth Q	74.57x
Revenue Growth Years	2x
Revenue Growth3 Y	8.82x
Revenue Growth5 Y	198.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.2
Assets	$38M
Cash	$32.8M
Current Assets	$41.2M
Current Liabilities	$1.9M
Debt	$65,668
Debt Equity	$0
Equity	$36.2M
Liabilities	$1.8M
Long Term Assets	$-3.2M
Long Term Liabilities	$-106,492
Net Cash	$32.8M
Net Cash By Market Cap	$37.81
Net Cash Growth	306.99%
Net Debt Equity	$-0.9
Tangible Book Value	$36.2M
Tangible Book Value Per Share	$0

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	21.98
Net Working Capital	$3.4M
Quick ratio	21.68
Working Capital	$36.2M
Working Capital Turnover	$0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-74.72%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.51%
1Y total return	17.98%
200-day SMA	4.02
3Y total return	53.29%
50-day SMA	3.88
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.43%
All Time High	797.4
All Time High Change	-99.42%
All Time High Date	2014-01-30
All Time Low	1
All Time Low Change	365.53%
All Time Low Date	2024-11-22
ATR	0.26
Ch YTD	51.3
High	4.73
High52	7
High52 Date	2025-07-25
High52ch	-33.43%
Low	4.55
Low52	2.66
Low52 Date	2025-12-18
Low52ch	75.19%
Ma50ch	20.2%
Premarket Change Percent	1.29
Premarket Price	$4.73
Premarket Volume	470
Price vs 200-day SMA	15.86%
RSI	60.93
RSI Monthly	56.73
RSI Weekly	61.78
Sharpe ratio	0.39x
Sortino ratio	0.7
Total Return	-74.72%
Tr YTD	51.3
Tr15y	-96.52%
Tr1m	23.94%
Tr1w	-1.38%
Tr3m	32.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-11.7M
Operating margin	-264.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,311,780,939%
Float Percent	76.43%
Net Borrowing	-90,706.4
Shares Insiders	4.73%
Shares Institutions	34.59%
Shares Out	10,875,416,329
Shares Qo Q	36.08%
Shares Yo Y	74.72%
Short Ratio	1.65
Short Shares	0.11

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.5M
Average Volume	27,617.6x
Bv Per Share	0
Ch10y	-87.51
Ch15y	-96.52
Ch1m	23.94
Ch1w	-1.38
Ch1y	17.98
Ch20y	-95.32
Ch3m	32.01
Ch3y	53.29
Ch5y	-64.43
Ch6m	34.68
Change	-0.21%
Change From Open	2.42
Close	4.67
Days Gap	-2.57
Depreciation Amortization	9,839.6
Dollar Volume	23,999.2
Earnings Date	2026-05-11
EBIT	$-11.7M
EBITDA	$-11.7M
EPS	$-0
F Score	3
FCF	$-9.9M
FCF EV Yield	-19.47x
FCF Per Share	$-0
Financing CF	39,069,140
Fiscal Year End	June
Founded	1,997
Income Tax	$86,461
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Date	2023-01-09
Last Split Type	Reverse
Last10k Filing Date	2025-08-29
Ma150	3.72
Ma150ch	25.3%
Ma20	4.44
Ma20ch	5.07%
Net CF	29,791,881
Next Earnings Date	2026-05-11
Open	4.55
Optionable	No
Position In Range	61.11
Post Close	4.66
Postmarket Change Percent	0.64
Postmarket Price	$4.69
Ppne	69,524
Pre Close	4.67
Price Date	2026-05-08
Ptbv Ratio	2.39
Relative Volume	0.19x
Revenue	4,426,642x
SBC By Revenue	36.17x
Share Based Comp	1,601,099
Tax By Revenue	1.95x
Tr20y	-95.32%
Tr6m	34.68%
Volume	5,150
Z Score	15.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ATHE pay a dividend?

Capital-return profile for this ticker.

Performance

ATHE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ATHE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.6%

Float: +76.4% of shares outstanding

Insider ownership

+4.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ATHE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.9

Neutral momentum band

Price vs 200-day MA

+15.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ATHE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ATHE stock rating?

Alterity Therapeutics Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ATHE analysis?

The full report lives at /stocks/ATHE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ATHE?

The latest report frames ATHE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ATHE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.